We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUV icon
1126
Nuveen Municipal Value Fund
NUV
$1.91B
$5.78M 0.01%
567,956
+29,127
+5% +$291K
IGM icon
1127
iShares Expanded Tech Sector ETF
IGM
$10.8B
$5.77M 0.01%
160,596
-66
-0% -$2.33K
BKLN icon
1128
Invesco Senior Loan ETF
BKLN
$6.74B
$5.76M 0.01%
254,116
-289
-0.1% -$6.59K
DPG
1129
Duff & Phelps Utility and Infrastructure Fund
DPG
$524M
$5.76M 0.01%
376,093
-2,193
-0.6% -$33.2K
DXC icon
1130
DXC Technology
DXC
$1.73B
$5.75M 0.01%
104,175
-163,575
-61% -$9.47M
SA
1131
Seabridge Gold
SA
$3.35B
$5.73M 0.01%
423,589
+296,075
+232% +$3.51M
VTWO icon
1132
Vanguard Russell 2000 ETF
VTWO
$17.4B
$5.72M 0.01%
91,508
-11,484
-11% -$712K
DVYE icon
1133
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$5.7M 0.01%
139,786
-1,790
-1% -$71.7K
DNOW icon
1134
DNOW Inc
DNOW
$2.99B
$5.7M 0.01%
386,143
-16,192
-4% -$232K
LOGM
1135
DELISTED
LogMein, Inc.
LOGM
$5.7M 0.01%
77,330
-998
-1% -$77.1K
WST icon
1136
West Pharmaceutical
WST
$24.9B
$5.69M 0.01%
45,482
-1,201
-3% -$142K
EGP icon
1137
EastGroup Properties
EGP
$10.9B
$5.69M 0.01%
49,046
-979
-2% -$111K
INTF icon
1138
iShares International Equity Factor ETF
INTF
$3.75B
$5.69M 0.01%
216,621
+72,563
+50% +$1.9M
P
1139
Everpure Inc
P
$29.9B
$5.68M 0.01%
371,738
+231,026
+164% +$4.51M
VSS icon
1140
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$5.67M 0.01%
53,861
+34,309
+175% +$3.58M
CARG icon
1141
CarGurus
CARG
$3.47B
$5.66M 0.01%
156,725
+51,072
+48% +$1.92M
DXCM icon
1142
DexCom
DXCM
$32B
$5.63M 0.01%
150,424
-25,260
-14% -$794K
USA icon
1143
Liberty All-Star Equity Fund
USA
$1.85B
$5.63M 0.01%
877,396
-42,331
-5% -$264K
HYLS icon
1144
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$5.63M 0.01%
116,923
+15,021
+15% +$722K
NFJ
1145
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.43B
$5.62M 0.01%
453,538
+11,487
+3% +$140K
QRVO icon
1146
Qorvo
QRVO
$8.74B
$5.61M 0.01%
84,208
-4,183
-5% -$291K
NID
1147
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
$5.58M 0.01%
415,811
-22,671
-5% -$302K
NHI icon
1148
National Health Investors
NHI
$3.65B
$5.54M 0.01%
70,943
+8,037
+13% +$625K
BMO icon
1149
Bank of Montreal
BMO
$127B
$5.54M 0.01%
73,438
+11,117
+18% +$850K
IBDO
1150
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$5.52M 0.01%
217,200
+36,287
+20% +$909K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.